• 1
    Klein P, Herzog AG. Hormonal effects on epilepsy in women. Epilepsia 1998;39: S916.
  • 2
    Velisek L, Veliskova J, Etgen AM, et al. Region-specific modulation of limbic seizure susceptibility by ovarian steroids. Brain Res 1999;842: 1328.DOI: 10.1016/S0006-8993(99)01858-2
  • 3
    Velisek L, Veliskova J, Moshe SL, et al. Prenatal morphine exposure alters ovarian steroid hormonal regulation of seizure susceptibility. Brain Res 1998;796: 24756.DOI: 10.1016/S0006-8993(98)00367-9
  • 4
    Jacono JJ, Robertson JM. The effects of estrogen, progesterone, and ionized calcium on seizures during the menstrual cycle of epileptic women. Epilepsia 1987;28: 5717.
  • 5
    Schwartz-Giblin S, Korotzer A, Pfaff DW. Steroid hormone effects on picrotoxin-induced seizures in female and male rats. Brain Res 1989;476: 2407.DOI: 10.1016/0006-8993(89)91244-4
  • 6
    Veliskova J, Velisek L, Galanopoulou AS, et al. Neuroprotective effects of estrogens on hippocampal cells in adult female rats after status epilepticus. Epilepsia 2000;41: S305.
  • 7
    Canger RAG, Battino D, Canevini MP. Modification of seizure frequency in pregnant patients with epilepsy: a prospective study. In: JanzDBA, DamM, HelgeH et al., eds. Epilepsy, pregnancy, and the child. New York : Raven Press, 1982: 338.
  • 8
    Knight AH, Rhind EG. Epilepsy and pregnancy: a study of 153 pregnancies in 59 patients. Epilepsia 1975;16: 99110.
  • 9
    Remillard GDL, Andermann E, Andermann F. Seizure frequency during pregnancy and the puerperium. In: JanzDBA, DamM, HelgeH et al., eds. Epilepsy, pregnancy, and the child. New York : Raven Press, 1982: 3949.
  • 10
    Yerby M. Treatment of epilepsy during pregnancy. In: WyllieE, ed. The treatment of epilepsy: principles and practice. Baltimore : Williams & Wilkins, 1997: 78598.
  • 11
    Otani K. Risk factors for the increased seizure frequency during pregnancy and puerperium. Folia Psychiatry Neurol Jpn 1985;39: 3341.
  • 12
    Hallak M, Kupsky WJ, Hotra JW, et al. Fetal rat brain damage caused by maternal seizure activity: prevention by magnesium sulfate. Am J Obstet Gynecol 1999;181: 82834.
  • 13
    Yerby MS. Problems and management of the pregnant woman with epilepsy. Epilepsia 1987;28: S2936.
  • 14
    Speidel BD, Meadow SR. Maternal epilepsy and abnormalities of the fetus and newborn. Lancet 1972;2: 83943.DOI: 10.1016/S0140-6736(72)92209-X
  • 15
    Burnett C. A survey of the relation between epilepsy and pregnancy. J Obstet Gynecol 1946;53: 53956.
  • 16
    Teramo KHV. Pregnancy and fetal complications in epileptic pregnancies: review of the literature. In: JanzDBA, DamM, HelgeHet al., eds. Epilepsy, pregnancy, and the child. New York : Raven Press; 1982: 539.
  • 17
    Bjerkedal T, Bahna SL. The course and outcome of pregnancy in women with epilepsy. Acta Obstet Gynecol Scand 1973;52: 2458.
  • 18
    Beaussart-Defaye JBN, Demarca C, Beaussart X. Epilepsies and reproduction. 2nd ed. Grine Lille , France : Nord Epilepsy Research and Information Group , 1986.
  • 19
    Yerby MS, Cawthon L. Infant mortality in infants of mothers with epilepsy. Epilepsia 1995;36: S90.
  • 20
    Bossi EA. Plasma levels and clinical effects of antiepileptic drugs in pregnant epileptic patients and their newborns. In: JohannsessenSIMP, PippengerCE, RichensA et al., eds. Antiepileptic therapy: advances in drug monitoring. New York : Raven Press, 1980: 914.
  • 21
    Annegers JF, Hauser WA, Elveback LR, et al. Congenital malformations and seizure disorders in the offspring of parents with epilepsy. Int J Epidemiol 1978;7: 2417.
  • 22
    Wendorff J, Juchniewicz B. [Occurrence of epilepsy, its types and course during the first decade of life in progeny of mothers with epilepsy: prospective study]. Przegl Lek 2001;58: 3740.
  • 23
    Ottman R, Annegers JF, Hauser WA, et al. Higher risk of seizures in offspring of mothers than of fathers with epilepsy. Am J Hum Genet 1988;43: 25764.
  • 24
    Nakane Y. Congenital malformation among infants of epileptic mothers treated during pregnancy: the report of a collaborative study group in Japan. Folia Psychiatry Neurol Jpn 1979;33: 3639.
  • 25
    Lindhout D, Meinardi H, Meijer JW, et al. Antiepileptic drugs and teratogenesis in two consecutive cohorts: changes in prescription policy paralleled by changes in pattern of malformations. Neurology 1992;42: 94110.
  • 26
    Loughnan PM, Gold H, Vance JC. Phenytoin teratogenicity in man. Lancet 1973;1: 702.DOI: 10.1016/S0140-6736(73)90467-4
  • 27
    Jones KL, Lacro RV, Johnson KA, et al. Pattern of malformations in the children of women treated with carbamazepine during pregnancy. N Engl J Med 1989;320: 16616.
  • 28
    Seip M. Growth retardation, dysmorphic facies and minor malformations following massive exposure to phenobarbitone in utero. Acta Paediatr Scand 1976;65: 61721.
  • 29
    Kaneko S, Otani K, Fukushima Y, et al. Teratogenicity of antiepileptic drugs: analysis of possible risk factors. Epilepsia 1988;29: 45967.
  • 30
    Zachai EH. The fetal trimethadione syndrome. J Pediatr 1975;87: 2804.
  • 31
    Volpe JJ. Neurology of the newborn. 3rd ed. Philadelphia : WB Saunders, 1995.
  • 32
    Yerby MS. Management issues for women with epilepsy: neural tube defects and folic acid supplementation. Neurology 2003;61 (6 suppl. 2):S236.
  • 33
    Hill RM, Verniaud WM, Horning MG, et al. Infants exposed in utero to antiepileptic drugs: a prospective study. Am J Dis Child 1974;127: 64553.
  • 34
    Gaily E, Granstrom ML, Hiilesmaa V, et al. Minor anomalies in offspring of epileptic mothers. J Pediatr 1988;112: 5209.
  • 35
    Leavitt AM, Yerby MS, Robinson N, et al. Epilepsy in pregnancy: developmental outcome of offspring at 12 months. Neurology 1992;42: 1413.
  • 36
    Bertolini R. Anticonvulsant drugs in monotherapy: effect on the fetus. Eur J Epidemiol 1987;3: 16471.
  • 37
    Jager- Roman. Somatic parameters, diseases, and psychomotor development in the offspring of epileptic parents. In: JanzDBA, DamM, HelgeHet al., eds. Epilepsy, pregnancy, and the child. New York : Raven Press; 1982: 42532.
  • 38
    Majewski F, Steger M, Richter B, et al. The teratogenicity of hydantoins and barbiturates in humans, with considerations on the etiology of malformations and cerebral disturbances in the children of epileptic parents. Int J Biol Res Pregnancy 1981;2: 3745.
  • 39
    Finnell RH, Buehler BA, Kerr BM, et al. Clinical and experimental studies linking oxidative metabolism to phenytoin-induced teratogenesis. Neurology 1992;42: 2531.
  • 40
    Dieterich E, Steveling A, Lukas A, et al. Congenital anomalies in children of epileptic mothers and fathers. Neuropediatrics 1980;11: 27483.
  • 41
    Gaily EK, Granstrom ML, Hiilesmaa VK, et al. Head circumference in children of epileptic mothers: contributions of drug exposure and genetic background. Epilepsy Res 1990;5: 21722.DOI: 10.1016/0920-1211(90)90041-S
  • 42
    Kelly TE, Edwards P, Rein M, et al. Teratogenicity of anticonvulsant drugs, II: a prospective study. Am J Med Genet 1984;19: 43543.
  • 43
    Nelson KB, Ellenberg JH. Maternal seizure disorder, outcome of pregnancy, and neurologic abnormalities in the children. Neurology 1982;32: 124754.
  • 44
    Yanai J, Rosselli-Austin L, Tabakoff B. Neuronal deficits in mice following prenatal exposure to phenobarbital. Exp Neurol 1979;64: 23744.
  • 45
    Middaugh LD, Santos CA 3rd, Zemp JW. Effects of phenobarbital given to pregnant mice on behavior of mature offspring. Dev Psychobiol 1975;8: 30513.
  • 46
    Vorhees CV. Fetal anticonvulsant syndrome in rats: dose- and period-response relationships of prenatal diphenylhydantoin, trimethadione and phenobarbital exposure on the structural and functional development of the offspring. J Pharmacol Exp Ther 1983;227: 27487.
  • 47
    Vorhees CV. Teratogenicity and developmental toxicity of valproic acid in rats. Teratology 1987;35: 195202.
  • 48
    Vorhees CV. Behavioral teratogenicity of valproic acid: selective effects on behavior after prenatal exposure to rats. Psychopharmacology (Berl) 1987;92: 1739.
  • 49
    Vorhees CV, Minck DR. Long-term effects of prenatal phenytoin exposure on offspring behavior in rats. Neurotoxicol Teratol 1989;11: 295305.DOI: 10.1016/0892-0362(89)90072-X
  • 50
    Chang T, Savory A, Glazko AJ. A new metabolite of 5,5-diphenylhydantoin (Dilantin). Biochem Biophys Res Commun 1970;38: 4449.
  • 51
    Yerby MS, Collins SD. Teratogenicity of antiepileptic drugs. In: EngelJPT, ed. Epilepsy: a comprehensive textbook. Philadelphia : Lippincott-Raven, 1997: 1195203.
  • 52
    Zhu MX, Zhou SS. Reduction of the teratogenic effects of phenytoin by folic acid and a mixture of folic acid, vitamins, and amino acids: a preliminary trial. Epilepsia 1989;30: 24651.
  • 53
    Biale Y, Lewenthal H. Effect of folic acid supplementation on congenital malformations due to anticonvulsive drugs. Eur J Obstet Gynecol Reprod Biol 1984;18: 2116.
  • 54
    Meador K. Cognitive effects of antiepileptic drugs. In: DevinksyOTW, ed. Epilepsy and behavior. New York : Wiley-Liss, 1991: 15170.